Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)

NCT00848484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MK5757
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC